Imiquimod approved for AKs


Washington - The U.S. Food and Drug Administration (FDA) has granted marketing approval for Aldara (imiquimod) Cream 5 percent for the treatment of actinic keratoses (AK) on the face or scalp in immunocompetent adults. It is the first immune response modifier (IRM) approved for AK.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.